KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash from Financing Activities (2016 - 2026)

Supernus Pharmaceuticals has reported Cash from Financing Activities over the past 15 years, most recently at $8.5 million for Q4 2025.

  • Quarterly Cash from Financing Activities rose 44.75% to $8.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, down 25.12% year-over-year, with the annual reading at $9.1 million for FY2025, 25.12% down from the prior year.
  • Cash from Financing Activities was $8.5 million for Q4 2025 at Supernus Pharmaceuticals, down from $21.1 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $80.2 million in Q1 2023 and troughed at -$478.9 million in Q2 2023.
  • The 5-year median for Cash from Financing Activities is $2.0 million (2021), against an average of -$25.9 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 6921.88% in 2021 and then tumbled 21169.78% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$136.7 million in 2021, then surged by 102.07% to $2.8 million in 2022, then tumbled by 61.4% to $1.1 million in 2023, then surged by 439.38% to $5.9 million in 2024, then surged by 44.75% to $8.5 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Cash from Financing Activities are $8.5 million (Q4 2025), $21.1 million (Q3 2025), and $935000.0 (Q2 2025).